Clinical Trial Update: A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111 [Phase 2]

View source ↗

Summary

A Phase 2 safety study of retinal gene therapy BIIB111 for choroideremia has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroideremia

Drugs mentioned

• BIIB111

Snippet

Sponsor: Biogen | Conditions: Choroideremia | Phase 2 | Status: COMPLETED | Results posted: 2023-09-18